Metabolism and body composition
5-amino-1MQ
Editorial audit: October 15, 2026 · draft; scientific, medical and translation review pending
01What is reported
5-amino-1MQ is included in peptide-oriented guides for fat loss and metabolic combinations, although it is a small molecule rather than a peptide.
02Proposed rationale
NNMT inhibition is proposed to alter metabolism. NNMT methylates nicotinamide; shorthand suggesting direct NAD methylation is inaccurate.
03What the research shows
The cited work includes mouse experiments. It does not establish the guide’s human dosing, cognitive benefits or longevity outcomes.
04Limits and unknowns
Putting a compound in a peptide book does not change its chemical class or confer clinical evidence. Combination claims require their own evaluation.
05Questions to ask about the product
Confirm the chemical identity and distinguish it from related inhibitors or similarly named research products.
06Open research question
How often do educational and commercial summaries misclassify the compound or extend animal endpoints into human claims?
Primary and regulatory references
- 1.